
BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
latest_posts
- 1
Flu season is just beginning, but doctors are already on high alert - 2
New research reveals urban raccoons across the US show early signs of domestication - 3
Tire Brands for Senior Drivers: Guaranteeing Security and Solace - 4
Interstellar comet 3I/ATLAS will fly by Earth Friday. Here are the latest images - 5
Trump announces 'Patriot Games' with 2 competitors from every state and territory: What we know
74 suicide warnings and 243 mentions of hanging: What ChatGPT said to a suicidal teen
Germany's Deutsche Welle broadcaster declared 'undesirable' in Russia
Track down the Ideal Weight reduction Methodology for Your Way of life
Parents who delay baby's first vaccines also likely to skip measles shots
The 15 Most Rousing TED Chats on Self-awareness
Modern surgery began with saws and iron hands – how amputation transformed the body in the Renaissance
Baikonur launch pad damaged after Russian Soyuz launch to International Space Station
Effectiveness Uncovered: A Survey of \Smoothing out Your Errands\ Efficiency Application
Well known Tea Brands for Each Tea Sweetheart












